GlassScriptPhysician profile
John Bojescul
NPI 1417914706
$6,216.19
in general payments reported to CMS, 2019-2025
27 companies · $268 in 2025
The $268 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,164 · 2020: $1,250 · 2021: $508 · 2022: $610 · 2023: $776 · 2024: $640 · 2025: $268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,684.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,684.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $1,886.87 | 2019-2025 | Monovisc, Orthovisc |
| Stryker Corporation | $1,056.67 | 2019-2025 | Mako |
| Linvatec Corporation | $831.42 | 2019 | |
| Miach Orthopaedics, INC. | $456.21 | 2023-2024 | |
| Smith+Nephew, INC. | $320.93 | 2023-2024 | Bone Anchors With Arthroscopic Delivery System, Evos, Evos Mini |
| Anika Therapeutics, INC. | $254.37 | 2022-2024 | Integrity, Sportsmed Portfolio, Tactoset |
| Nextstep Arthropedix, LLC | $184.89 | 2023 | Insitu Hip System |
| Zimmer Biomet Holdings, INC. | $174.62 | 2020-2024 | Mymobility Platform |
| Medical Device Business Services, INC. | $144.55 | 2019-2020 | |
| Arthrex, INC. | $122.88 | 2022 | |
| Arthrosurface Incorporated | $115.76 | 2019 | |
| Engage Uni, LLC | $114.00 | 2021 | |
| Convatec INC. | $99.52 | 2019-2023 | |
| Team 1, LLC | $98.93 | 2025 | |
| Horizon Therapeutics Plc | $61.17 | 2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ermi LLC | $57.05 | 2019 | |
| Acelrx Pharmaceuticals, INC. | $36.03 | 2019-2020 | |
| Osteoremedies, LLC | $31.25 | 2019 | |
| Ferring Pharmaceuticals INC. | $28.03 | 2020-2021 | |
| Bioventus LLC | $24.37 | 2021 | |
| Trice Medical, INC. | $22.12 | 2019 | |
| Heraeus Medical, LLC. | $21.25 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $19.20 | 2023 | |
| Moximed, INC | $17.69 | 2025 | Misha Knee System, Small, Left |
| Abbott Laboratories | $12.81 | 2022 | |
| Orthogenrx INC. | $12.44 | 2019 | |
| Endo Pharmaceuticals INC. | $11.16 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Bojescul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.